CAMP4 Announces Pricing of $30.0 Million Underwritten Offering of Common Stock

(NasdaqGM:CAMP), CAMBRIDGE, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) — CAMP4 Therapeutics Corporation (“CAMP4” or the “Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels to treat a broad range of genetic diseases, today announced the pricing of […]

CAMP4 Announces Pricing of $30.0 Million Underwritten Offering of Common Stock

CAMP4 Announces Pricing of $30.0 Million Underwritten Offering of Common Stock GlobeNewswire December 18, 2025 CAMBRIDGE, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) — CAMP4 Therapeutics Corporation (“CAMP4” or the “Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein

PowerBank’s First Solar Project Under Development for Fiera Real Estate Reaches Commercial Operation

$12.0 billion USD in commercial real estate managed by Fiera Real Estate, PowerBank anticipates future projects 1.45-Megawatt rooftop project completed as a pilot project PowerBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: 103) (“PowerBank” or the “Company”) announces that the 1.45 MW DC rooftop solar project located in Calgary, Alberta (the “Project”) for Fiera Real

Hamilton Zanze Announces Sale of Platte View Landing

Firm Owned the 169-Home Brighton, Colo., Community for 19 Years Hamilton Zanze, a leading San Francisco-based multifamily real estate investment firm, announced today that it has sold Platte View Landing, a 169-unit garden-style community in Brighton, Colo. The firm sponsored the acquisition of the property in 2006 and closed the sale on Dec. 9. https://mma.prnewswire.com/media/2848047/Hamilton_Zanze_and_Company_Platte_View_Landing_in_Brighton.jpg

REGENXBIO to Present at the 44th Annual J.P. Morgan Healthcare Conference

REGENXBIO Inc. (Nasdaq: RGNX) today announced it will present at the 44th Annual J.P. Morgan Healthcare Conference. Presentation DetailsDate and Time: Wednesday, January 14, 2026 at 10:30 a.m. PT Location:Westin St. Francis,San Francisco, CA A live webcast of the presentation can be accessed in the Investors section of REGENXBIO's website at www.regenxbio.com. An archived replay

AHN Launches New Campaign, ‘Tell Us’ Aimed at Changing the Conversation over Annual OB-GYN Exams

To Coincide with the Campaign's Launch,AHN to Introduce First-of-its Kind 'Panty Pouch' to OB-GYN Clinics for Patient Undergarments, Easing an Unspoken Worry for Many Patients In August,Allegheny Health Network's (AHN) Women's Institute launched “Tell Us” – a multiplatform marketing campaign designed to encourage women to schedule annual OB-GYN exams and normalize open discussion about their

Integer Holdings Corporation (ITGR) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of February 9, 2026 Deadline

NEW YORK, NY / ACCESS Newswire / December 18, 2025 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Integer Holdings Corporation (NYSE:ITGR) securities. If you suffered a loss on your Integer Holdings Corporation investment and would like to explore

Parkit Completes Sale of Winnipeg Property and Adds To Investment in PROREIT

Toronto, Ontario–(Newsfile Corp. – December 18, 2025) – Parkit Enterprise Inc. (TSXV: PKT) (“Parkit” or the “Company”), has completed the sale of its remaining property located in Winnipeg, Manitoba (the “Property“) to PRO Real Estate Investment Trust (TSX: PRV.UN) (“PROREIT“) for proceeds of $5,350,000, subject to customary adjustments (the “Transaction“). Parkit received $2,140,000 of the proceeds in

NRx Pharmaceuticals (Nasdaq:NRXP) announces elimination of all balance sheet debt following equity conversion

(NasdaqGM:NRXP), Remaining $5.4 million debt was repaid through strategic equity conversion in common stock with no additional warrants or adjustment provisions Company anticipates that Dec 31 balance sheet will reflect no outstanding convertible debt Debt-free balance sheet sets the stage for accelerated growth in 2026 with potential drug approvals and clinic expansions WILMINGTON, Del., Dec.

Scroll to Top